# Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation

> **NCT07273994** · PHASE4 · RECRUITING · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 312 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **DRUG:** Amiodarone Hydrochloride 200 MG
- **DRUG:** Amiodarone Hydrochloride 100 MG

## Key facts

- **NCT ID:** NCT07273994
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2027-12
- **Final completion:** 2028-04
- **Target enrollment:** 312 (ESTIMATED)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07273994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07273994, "Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07273994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*